Urinary ATP May Be a Dynamic Biomarker of Detrusor Overactivity in Women with Overactive Bladder Syndrome

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Silva Ramos, Miguel ^a,b   Silva, Isabel ^a   Oliveira, Olga ^a,b   Ferreira, Sónia ^a,b   Reis, Maria Júlia ^b   Oliveira, José Carlos ^b   Correia de Sá, Paulo ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b Institute of Biomedical Sciences Abel Salazar   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; BIOLOGICAL MARKER; CREATININE; LUCIFERASE; LUCIFERIN; NERVE GROWTH FACTOR;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BIOLUMINESCENCE; BLOOD SAMPLING; CONTROLLED STUDY; CREATININE CLEARANCE; CREATININE URINE LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUID INTAKE; HUMAN; MAJOR CLINICAL STUDY; MICTURITION; OVERACTIVE BLADDER; RECEIVER OPERATING CHARACTERISTIC; URINALYSIS;

ADENOSINE TRIPHOSPHATE; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CREATININE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MIDDLE AGED; NERVE GROWTH FACTOR; ROC CURVE; URINARY BLADDER, OVERACTIVE; URINATION; URODYNAMICS;

EID: 84878580793     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064696     Document Type: Article

References (42)

1. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, et al. (2002) The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 21: 167-178.
2. Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, et al. (2006) Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 50: 1306-1314.
3. Coyne KS, Sexton CC, Kopp ZS, Ebel-Bitoun C, Milsom I, et al. (2011) The impact of overactive bladder on mental health, work productivity and health-related quality of life in the UK and Sweden: results from EpiLUTS. BJU Int 108: 1459-71.
4. Bates CP, Whiteside CG, Turner-Warwick R, (1970) Synchronous cine-pressure-flow-cysto-urethrography with special reference to stress and urge incontinence. Br J Urol 42: 714-723.
5. Hashim H, Abrams P, (2006) Is the bladder a reliable witness for predicting detrusor overactivity? J Urol 175: 191-194.
6. Brostrom S, Jennum P, Lose G, (2002) Short-term reproducibility of cystometry and pressure-flow micturition studies in healthy women. Neurourol Urodyn 21: 457-460.
7. Nitti VW, Rovner ES, Bavendam T, (2010) Response to fesoterodine in patients with an overactive bladder and urgency urinary incontinence is independent of the urodynamic finding of detrusor overactivity. BJU Int 105: 1268-1275.
8. Rovner E, Kennelly M, Schulte-Baukloh H, Zhou J, Haag-Molkenteller C, et al. (2011) Urodynamic results and clinical outcomes with intradetrusor injections of onabotulinumtoxinA in a randomized, placebo-controlled dose-finding study in idiopathic overactive bladder. Neurourol Urodyn 30: 556-562.
9. Farag FF, Heesakkers JP, (2011) Non-invasive techniques in the diagnosis of bladder storage disorders. Neurourol Urodyn 30(8): 1422-8.
10. Cartwright R, Afshan I, Derpapas A, Vijava G, Khullar V, (2011) Novel biomarkers for overactive bladder. Nat Rev Urol 8(3): 139-45.
11. Kuo HC, Liu HT, Chancellor MB, (2010) Urinary nerve growth factor is a better biomarker than detrusor wall thickness for the assessment of overactive bladder with incontinence. Neurourol Urodyn 29(3): 482-7.
12. Liu HT, Chen CY, Kuo HC, (2010) Urinary nerve growth factor levels in overactive bladder syndrome and lower urinary tract disorders. J Formos Med Assoc 109(12): 862-78.
13. Ochodnický P, Cruz CD, Yoshimura N, Michel MC, (2011) Nerve growth factor in bladder dysfunction: contributing factor, biomarker, and therapeutic target. Neurourol Urodyn 30(7): 1227-1241.
14. Ruggieri MR Sr, (2006) Mechanisms of disease: role of purinergic signaling in the pathophysiology of bladder dysfunction. Nat Clin Pract Urol 3: 206-215.
15. Burnstock G, (2011) Therapeutic potential of purinergic signalling for diseases of the urinary tract. BJU Int 107: 192-204.
16. Ferguson DR, Kennedy I, Burton TJ, (1997) ATP is released from rabbit urinary bladder epithelial cells by hydrostatic pressure changes-a possible sensory mechanism? J Physiol (London) 505: 503-511.
17. Wang EC, Lee JM, Ruiz WG, Balestreire EM, von Bodungen M, et al. (2005) ATP and purinergic receptor-dependent membrane traffic in bladder umbrella cells. J Clin Invest 115: 2412-2422.
18. Ito K, Iwami A, Katsura H, Ikeda M, (2008) Therapeutic effects of the putative P2X3/P2X2/3 antagonist A-317491 on cyclophosphamide-induced cystitis in rats. Naunyn Schmiedeberg's Arch Pharmacol 377: 483-490.
19. Cockayne DA, Hamilton SG, Zhu QM, Dunn PM, Zhong Y, et al. (2000) Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice. Nature 407: 1011-1015.
20. Moore KH, Gilpin SA, Dixon JS, Richmond DH, Sutherst JR, (1992) Increase in presumptive sensory nerves of the urinary bladder in idiopathic Detrusor instability. Br J Urol 70(4): 370-2.
21. Pandita RK, Andersson KE, (2002) Intravesical adenosine triphosphate stimulates the micturition reflex in awake, freely moving rats. J Urol 168: 1230-1234.
22. Fry CH, Sui GP, Kanai AJ, Wu C (2007) The function of suburothelial myofibroblasts in the bladder. Neurourol Urodyn 26(6 Suppl): 914-919.
23. Khera M, Somogyi GT, Kiss S, Boone TB, Smith CP, (2004) Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury. Neurochem Int 45: 987-993.
24. Smith CP, Vemulakonda VM, Kiss S, Boone TB, Somogyi GT, (2005) Enhanced ATP release from rat bladder urothelium during chronic bladder inflammation: effect of botulinum toxin A. Neurochem Int. 47: 291-297.
25. Munoz A, Smith CP, Boone TB, Somogyi GT, (2011) Overactive and underactive bladder dysfunction is reflected by alterations in utothelial ATP and NO release. Neurochem Int 58: 295-300.
26. Kumar V, Chapple CR, Rosario D, Tophill PR, Chess-Williams R, (2010) In vitro release of adenosine triphosphate from the urothelium of human bladders with detrusor overactivity, both neurogenic and idiopathic. Eur Urol 57: 1087-1092.
27. Silva-Ramos M, Silva I, Duarte-Araújo M, Magalhães-Cardoso T, Lafuente-de-Carvalho J, et al. (2010) Loss of balance between excitatory P2X3 and inhibitory A1 receptors contribute to cholinergic hyperactivity in obstructed human bladder. Basic Clin Pharmacol Toxicol 107: 2397.
28. Kumar V, Chapple CC, Chess-Williams R, (2004) Characteristics of adenosine triphosphate release from porcine and human normal bladder. J Urol 172: 744-747.
29. Cheng Y, Mansfield KJ, Allen W, Walsh CA, Burcher E, et al. (2010) Does adenosine triphosphate release into voided urodynamic fluid contribute to urgency signaling in women with bladder dysfunction? J Urol 183: 1082-1086.
30. Cheng Y, Mansfield KJ, Allen W, Millard RJ, Burcher E, et al. (2012) Correlation between cystometric volumes, ATP release, and pH in women with overactive bladder versus controls. Neurourol Urodyn. doi: 10.1002/nau.22344.
31. Keiding R, Hörde M, Gerhard W, Denmark E, (1974) Recommended methods for the determination of four enzymes in blood. Scand J Clin Lab Invest 1: 271-74.
32. Sugaya K, Nishijima S, Kadekawa K, Miyazato M, Mukouyama H, (2009) Relationship between lower urinary tract symptoms and urinary ATP in patients with benign prostatic hyperplasia or overactive bladder. Biomed Res 30: 287-94.
33. Moore KH, Richmond DH, Sutherst JR, (1990) Urinary acidity in relation to detrusor instability. Neurourol Urodynam 9: 331-332.
34. Egan JP (1975) Signal Detection Theory and ROC Analysis. In Series in Cognitition and Perception. New York: Academic Press.
35. Kim JC, Park EY, Seo SI, Park YH, Hwang TK, (2006) Nerve growth factor and prostaglandins in the urine of female patients with overactive bladder. J Urol 175: 1773-6.
36. Antunes-Lopes T, Carvalho-Barros S, Cruz CD, Cruz F, Martins-Silva C (2011) Biomarkers in overactive bladder: a new objective and noninvasive tool? Adv Urol. doi: 10.1155/2011/382431.
37. Harvey RA, Skennerton DE, Newgreen D, Fry CH, (2002) The contractile potency of adenosine triphosphate and ecto-adenosine triphosphatase activity in guinea pig detrusor and detrusor from patients with a stable, unstable or obstructed bladder. J Urol 168: 1235-1239.
38. Silva I, Correia J, Ferreirinha F, Magalhães-Cardoso MT, Silva-Ramos M, et al. (2011) Bladder overactivity due to global impairment of ecto-NTPDases in humans with lower urinary tract disorders exhibiting unbalanced ATP/adenosine formation. Auton Neurosci Basic Clinical 163: 49-50.
39. Castrén E, Rantamäki T, (2010) Role of brain-derived neurotrophic factor in the aetiology of depression: implications for pharmacological treatment. CNS Drugs 24: 1-7.
40. Yu YB, Zuo XL, Zhao QJ, Chen FX, Yang J, et al. (2012) Brain-derived neurotrophic factor contributes to abdominal pain in irritable bowel syndrome. Gut 61: 685-694.
41. Munoz A, Gangitano DA, Smith CP, Boone TB, Somogyi GT, (2010) Removal of urothelium affects bladder contractility and release of ATP but not release of NO in rat urinary bladder. BMC Urol 10: 10 doi:10.1186/1471-2490-10-10.
42. Sadananda P, Shang F, Liu L, Mansfield KJ, Burcher E, (2009) Release of ATP from rat urinary bladder mucosa: role of acid, vanilloids and stretch. Br J Pharmacol 158: 1655-1662.